Latest stories on RNXT
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
Business Insider50 · neutralgeneral
RenovoRx Stockholders Approve Directors and Equity Plan
TipRanks50 · neutralgeneral
RenovoRx, Inc. (RNXT) files 8-K
SEC 8-K50 · neutralgeneral
RenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer | RNXT Stock News
StockTitan67 · bullishproduct/pr
RenovoRx Earnings Call Signals Commercial Inflection
TipRanks63 · neutralearnings